4//SEC Filing
Prothena Corp plc 4
Accession 0000899243-15-003754
$PRTACIK 0001559053operating
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:05 PM ET
Size
14.6 KB
Accession
0000899243-15-003754
Insider Transaction Report
Form 4
Schenk Dale B.
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2015-08-20$6.03/sh+33,333$200,998→ 33,333 total - Sale
Ordinary Shares, par value $0.01 per share
2015-08-20$55.82/sh−9,300$519,135→ 24,033 total - Sale
Ordinary Shares, par value $0.01 per share
2015-08-20$56.73/sh−13,600$771,490→ 10,433 total - Sale
Ordinary Shares, par value $0.01 per share
2015-08-20$57.59/sh−7,100$408,922→ 3,333 total - Exercise/Conversion
Stock Option (right to buy)
2015-08-20−33,333→ 416,667 totalExercise: $6.03Exp: 2023-01-29→ Ordinary Shares (33,333 underlying)
Holdings
- 8,211(indirect: By Trust)
Ordinary Shares, par value $0.01 per share
Footnotes (6)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $55.19 to $56.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $56.21 to $57.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]The transaction was executed in multiple trades in prices ranging from $57.22 to $58.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F5]The shares are held by the Schenk Family Trust, dated 2/9/2004, of which Reporting Person is a Co Trustee with his spouse.
- [F6]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship on each such vesting date.
Documents
Issuer
Prothena Corp plc
CIK 0001559053
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001559053
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 4:05 PM ET
- Size
- 14.6 KB